BSE SME Listed Aptus Pharma Limited Doubles Revenue, Builds 250 Plus Product Portfolio, and Accelerates Multi-Vertical Expansion
New Delhi [India], April 29: In a strong phase of growth and execution, Aptus Pharma Limited has delivered a standout performance with revenue doubling and a robust increase in net profit, reflecting both scale and operational strength. Key Standalone Financial Highlights (Rs. In Lakhs) Established in 2010, the company has evolved into a fast-growing pharmaceutical player […]
Continue Reading